{"id":1603,"date":"2025-08-02T02:04:23","date_gmt":"2025-08-02T02:04:23","guid":{"rendered":"https:\/\/www.bearsavings.com\/blog\/?p=1603"},"modified":"2025-08-02T02:04:25","modified_gmt":"2025-08-02T02:04:25","slug":"are-healthcare-stocks-still-a-good-investment-in-2025","status":"publish","type":"post","link":"https:\/\/www.bearsavings.com\/blog\/are-healthcare-stocks-still-a-good-investment-in-2025\/","title":{"rendered":"Are Healthcare Stocks Still a Good Investment in 2025?"},"content":{"rendered":"
<\/div>\n

Healthcare stocks have been long hailed as a defensive, long-term \u201cbuy and hold\u201d staple. Over the decades, the sector was there for investors in both good times and bad. A safe haven during downturns. A source of steady earnings growth and predictable dividends.<\/p>\n\n\n\n

Fast forward to 2025, and investors are reevaluating this thesis. After several years of market leadership, healthcare has been thrown on the defensive in 2025.<\/p>\n\n\n\n

Cost headwinds. Policy uncertainty. Investor rotation into high-flying tech.<\/p>\n\n\n\n

The stocks are getting hammered.<\/p>\n\n\n\n

Widely respected bellwethers like UnitedHealth (UNH) and Novo Nordisk (NVO) have shed more than 20% of their market value so far this year.<\/p>\n\n\n\n

Is this an early cycle flush? Or has the healthcare bull market already run its course?<\/p>\n\n\n\n

Let\u2019s dig into the sector\u2019s recent performance, structural outlook, and investment implications in more detail.<\/p>\n\n\n\n

\n\n\n\n
\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n